← Back to All US Stocks

OSR Holdings, Inc. (OSRHW) Stock Fundamental Analysis & AI Rating 2026

OSRHW Nasdaq Surgical & Medical Instruments & Apparatus DE CIK: 0001840425
Recently Updated • Analysis: Apr 13, 2026 • SEC Data: 2025-12-31
STRONG SELL
95% Conf
Pending
Analysis scheduled

📊 OSRHW Key Takeaways

Revenue: $2.9M
Net Margin: -619.8%
Free Cash Flow: $-4.3M
Current Ratio: 0.16x
Debt/Equity: 0.00x
EPS: $-0.80
AI Rating: STRONG SELL with 95% confidence
OSR Holdings, Inc. (OSRHW) receives a STRONG SELL rating with 95% confidence from our AI fundamental analysis based on SEC 10-K filings. With revenue of $2.9M, net profit margin of -619.8%, and return on equity (ROE) of -14.2%, OSR Holdings, Inc. demonstrates mixed fundamentals in the Healthcare sector. Below is our complete OSRHW stock analysis for 2026.

Is OSR Holdings, Inc. (OSRHW) a Good Investment?

Claude

OSR Holdings faces a severe financial distress situation with catastrophic operating losses (-631% margin) on contracting revenue (-17.7% YoY), coupled with a critical liquidity crisis (current ratio 0.16x) that threatens the company's ability to meet short-term obligations. At a cash burn rate of -4.3M operating cash flow against only 1.7M in cash, the company has limited runway unless dramatic operational improvements materialize immediately.

Why Buy OSR Holdings, Inc. Stock? OSRHW Key Strengths

Claude
  • + Zero long-term debt provides solvency buffer
  • + Positive gross profit of 592.9K on revenue base
  • + Net losses improving 33.4% YoY and EPS improving 83.3% YoY, indicating potential trend reversal

OSRHW Stock Risks: OSR Holdings, Inc. Investment Risks

Claude
  • ! Critical liquidity crisis with current ratio of 0.16x - unable to cover current liabilities with current assets
  • ! Operating losses of -18.3M on revenue of 2.9M indicate non-viable business model at current scale
  • ! Negative operating cash flow of -4.3M with minimal cash position of 1.7M creates near-term insolvency risk
  • ! Revenue declining 17.7% YoY suggests market rejection or demand collapse
  • ! Extremely low gross margin of 20.4% for medical device sector limits pricing power and profitability potential
  • ! No insider activity in 90 days may signal lack of confidence from management

Key Metrics to Watch

Claude
  • * Operating cash flow trend - must turn positive to avoid cash depletion
  • * Cash balance depletion rate - critical at -4.3M annual burn against 1.7M reserves
  • * Revenue stabilization and return to growth - currently in -17.7% decline
  • * Path to EBITDA and operating profitability - currently -631% operating margin
  • * Current ratio improvement - must exceed 1.0x to resolve liquidity crisis

OSR Holdings, Inc. (OSRHW) Financial Metrics & Key Ratios

Revenue
$2.9M
Net Income
$-18.0M
EPS (Diluted)
$-0.80
Free Cash Flow
$-4.3M
Total Assets
$171.2M
Cash Position
$1.7M

💡 AI Analyst Insight

The current ratio below 1.0x warrants monitoring of short-term liquidity.

OSRHW Profit Margin, ROE & Profitability Analysis

Gross Margin 20.4%
Operating Margin -631.0%
Net Margin -619.8%
ROE -14.2%
ROA -10.5%
FCF Margin -149.0%

OSRHW vs Healthcare Sector: How OSR Holdings, Inc. Compares

How OSR Holdings, Inc. compares to Healthcare sector averages

Net Margin
OSRHW -619.8%
vs
Sector Avg 12.0%
OSRHW Sector
ROE
OSRHW -14.2%
vs
Sector Avg 15.0%
OSRHW Sector
Current Ratio
OSRHW 0.2x
vs
Sector Avg 2.0x
OSRHW Sector
Debt/Equity
OSRHW 0.0x
vs
Sector Avg 0.6x
OSRHW Sector

Sector benchmarks are approximate industry averages. Actual sector performance may vary.

Is OSR Holdings, Inc. Stock Overvalued? OSRHW Valuation Analysis 2026

Based on fundamental analysis, OSR Holdings, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.

Return on Equity
-14.2%
Sector avg: 15%
Net Profit Margin
-619.8%
Sector avg: 12%
Revenue Growth
N/A
Year-over-year
Debt/Equity
0.00x
Sector avg: 0.6x

Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.

OSR Holdings, Inc. Balance Sheet: OSRHW Debt, Cash & Liquidity

Current Ratio
0.16x
Quick Ratio
0.15x
Debt/Equity
0.00x
Debt/Assets
25.8%
Interest Coverage
-286,500.05x
Long-term Debt
$0.0

OSRHW Revenue & Earnings Growth: 5-Year Financial Trend

OSRHW 5-year financial data: Year 2025: Revenue $3.5M, Net Income N/A, EPS $-4.79.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: OSR Holdings, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-4.79 indicates the company is currently unprofitable.

OSRHW Revenue Growth, EPS Growth & YoY Performance

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
-149.0%
Free cash flow / Revenue

OSRHW Quarterly Earnings & Performance

Quarterly financial performance data for OSR Holdings, Inc. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q2 2025 $881.8K -$2.3M $-0.69
Q1 2025 $761.3K -$3.4M N/A

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

OSR Holdings, Inc. Dividends, Buybacks & Capital Allocation

Operating Cash Flow
-$4.3M
Cash generated from operations
Stock Buybacks
$36.2M
Shares repurchased (TTM)
Capital Expenditures
$2.7K
Investment in assets
Dividends
None
No dividend program

OSRHW SEC Filings: Latest 10-K & 10-Q Analysis

Access official SEC EDGAR filings for OSR Holdings, Inc. (CIK: 0001840425)

📋 Recent SEC Filings

Date Form Document Action
Apr 9, 2026 8-K ea0285550-8k_osr.htm View →
Apr 2, 2026 8-K ea0284791-8k_osr.htm View →
Mar 31, 2026 10-K ea0283154-10k_osrhold.htm View →
Mar 16, 2026 8-K ea0281786-8k_osr.htm View →
Mar 10, 2026 8-K ea0280743-8k_osr.htm View →

Frequently Asked Questions about OSRHW

What is the AI rating for OSRHW?

OSR Holdings, Inc. (OSRHW) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.

What are OSRHW's key strengths?

Claude: Zero long-term debt provides solvency buffer. Positive gross profit of 592.9K on revenue base.

What are the risks of investing in OSRHW?

Claude: Critical liquidity crisis with current ratio of 0.16x - unable to cover current liabilities with current assets. Operating losses of -18.3M on revenue of 2.9M indicate non-viable business model at current scale.

What is OSRHW's revenue and growth?

OSR Holdings, Inc. reported revenue of $2.9M.

Does OSRHW pay dividends?

OSR Holdings, Inc. does not currently pay dividends.

Where can I find OSRHW SEC filings?

Official SEC filings for OSR Holdings, Inc. (CIK: 0001840425) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.

What is OSRHW's EPS?

OSR Holdings, Inc. has a diluted EPS of $-0.80.

How is the AI analysis conducted?

Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.

Is OSRHW a good stock to buy right now?

Based on our AI fundamental analysis in April 2026, OSR Holdings, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.

Is OSRHW stock overvalued or undervalued?

Valuation metrics for OSRHW: ROE of -14.2% (sector avg: 15%), net margin of -619.8% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.

Should I buy OSRHW stock in 2026?

Our dual AI analysis gives OSR Holdings, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.

What is OSRHW's free cash flow?

OSR Holdings, Inc.'s operating cash flow is $-4.3M, with capital expenditures of $2.7K. FCF margin is -149.0%.

How does OSRHW compare to other Healthcare stocks?

Vs Healthcare sector averages: Net margin -619.8% (avg: 12%), ROE -14.2% (avg: 15%), current ratio 0.16 (avg: 2).

Top Rated Stocks
NSSC 92% MLI 92% MELI 92% MDXG 92% MANH 92% INVA 92% GGG 92% GCT 92% FTNT 92% FSLR 92%
Sector: All Healthcare Stocks →
Disclaimer: This analysis is generated by Claude AI (Anthropic) and ChatGPT (OpenAI) based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Apr 13, 2026 | Data as of: 2025-12-31 | Powered by Claude AI